We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.8B
AUM Growth
+$2.95B
Cap. Flow
+$1.1B
Cap. Flow %
4.63%
Top 10 Hldgs %
44.66%
Holding
165
New
18
Increased
38
Reduced
31
Closed
20

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.14B
2
AMZN icon
Amazon
AMZN
+$601M
3
AON icon
Aon
AON
+$226M
4
TMO icon
Thermo Fisher Scientific
TMO
+$145M
5
AZEK
The AZEK Co
AZEK
+$100M

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$816M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$403M
3
EXEL icon
Exelixis
EXEL
+$260M
4
MSFT icon
Microsoft
MSFT
+$234M
5
INTU icon
Intuit
INTU
+$205M

Sector Composition

Rank Sector Weight
1 Healthcare 32.61%
2 Technology 13.02%
3 Financials 8.98%
4 Communication Services 7.2%
5 Industrials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBRX icon
151
Forte Biosciences
FBRX
$1.57B
– –
-70,429
Closed -$547K
IBB icon
152
PUT
iShares Biotechnology ETF
IBB
$9.77B
– –
-3,600,000
Closed -$460M
JNPR
153
DELISTED
Juniper Networks
JNPR
– –
-295,000
Closed -$10.7M
RXST icon
154
RxSight
RXST
$260M
– –
-175,000
Closed -$4.42M
SIMO icon
155
Silicon Motion
SIMO
$8.68B
– –
-29,298
Closed -$1.48M
SPY icon
156
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
– –
-3,300,000
Closed -$1.85B
SRPT icon
157
Sarepta Therapeutics
SRPT
$1.77B
– –
-2,341,424
Closed -$149M
TMDX icon
158
Transmedics
TMDX
$2.91B
– –
-3,000
Closed -$202K
X
159
DELISTED
US Steel
X
– –
-2,135,000
Closed -$90.2M
ZYME icon
160
Zymeworks
ZYME
$1.67B
– –
-400,000
Closed -$4.76M
SGI
161
Somnigroup International
SGI
$13.7B
– –
-1,326,242
Closed -$79.4M
GATE
162
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
– –
-150,000
Closed -$1.66M
GATEW
163
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
– –
-1,485,000
Closed -$238K
ITCI
164
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-3,055,000
Closed -$403M
3 4 5 6
7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Farallon Capital Management held 165 positions worth $23.8B, up 14% from $20.9B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Farallon Capital Management deployed $1.1B of net new capital in Q2 2025, opening 18 new positions and adding to 38 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 5,500,000 shares worth $3.4B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 38% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Exelixis, an estimated $260M trimmed.

  • Farallon Capital Management's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 5,500,000 shares worth $3.4B.
  • Farallon Capital Management added most to Aon in Q2 2025, an estimated $226M increase.
  • Farallon Capital Management's biggest Q2 2025 reduction was Exelixis, cutting an estimated $260M.
  • Farallon Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $816M.
  • Farallon Capital Management's ten largest holdings make up 45% of its $23.8B portfolio in Q2 2025.
  • Farallon Capital Management opened 18 new positions and closed 20 in Q2 2025.
  • Farallon Capital Management's portfolio value rose 14% quarter-over-quarter to $23.8B.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.